Skip to main content
. Author manuscript; available in PMC: 2022 Aug 2.
Published in final edited form as: J Vasc Interv Radiol. 2022 Mar 26;33(7):764–774.e4. doi: 10.1016/j.jvir.2022.03.026

Table 2.

Average Cell Positivity (counts/μm2) on Immunohistochemistry Stainings Summarized as Mean ± SEM.

Control Bicarbonate
C BC cT cTB OT OTB LT LTB
Tumor edge
 CD3 0.25 ± 0.06 0.16 ± 0.1 0.16 ± 0.01 0.25 ± 0.1 0.42 ± 0.05 0.43 ± 0.01 0.2 ± 0.1 0.25 ± 0.01
 HLA-DR 0.57 ± 0.25 0.35 ± 0.16 0.27 ± 0.09 0.39 ± 0.12 0.55 ± 0.14 0.66 ± 0.09 0.48 ± 0.1 0.52 ± 0.17
 CTLA-4 1.72 ± 0.17 0.49 ± 0.1 0.27 ± 0.18 0.19 ± 0.16 0.22 ± 0.12 0.1 ± 0.03 0.68 ± 0.15 0.64 ± 0.15
 PD-1 0.97 ± 0.1 0.48 ± 0.1 0.43 ± 0.08 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.21 ± 0.1 0.32 ± 0.04
 PD-L1 0.84 ± 0.06 0.45 ± 0.04 0.21 ± 0.06 0.5 ± 0.0 0.34 ± 0.1 0.35 ± 0.12 0.43 ± 0.16 0.42 ± 0.03
Tumor core
 CD3 0.37 ± 0.09 0.26 ± 0.08 0.03 ± 0.02 0.26 ± 0.1 0.32 ± 0.07 0.43 ± 0.01 0.33 ± 0.2 0.49 ± 0.3
 HLA-DR 0.63 ± 0.05 0.53 ± 0.07 0.29 ± 0.14 0.54 ± 0.1 0.48 ± 0.08 0.7 ± 0.18 0.78 ± 0.1 1.02 ± 0.27
 CTLA-4 1.78 ± 0.16 0.7 ± 0.3 0.02 ± 0.0 0.15 ± 0.09 0.02 ± 0.0 0.03 ± 0.02 0.6 ± 0.31 0.58 ± 0.01
 PD-1 1.3 ± 0.23 0.7 ± 0.28 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.5 ± 0.1 0.0 ± 0.0
 PD-L1 1.09 ± 0.2 1.02 ± 0.21 0.3 ± 0.11 1.0 ± 0.0 0.29 ± 0.09 0.54 ± 0.25 0.86 ± 0.24 0.7 ± 0.1

BC = bicarbonate; C = control; cT = conventional transcatheter arterial chemoembolization; CD = cluster of differentiation; cTB = conventional transcatheter arterial chemoembolization + bicarbonate; CTLA-4 = cytotoxic T-lymphocyte–associated protein-4; HLA-DR = human leukocyte antigen DR type; LT = LUMI-bead transcatheter arterial chemoembolization; LTB = LUMI-bead transcatheter arterial chemoembolization + bicarbonate; OT = Oncozene-microsphere transcatheter arterial; OTB = Oncozene-microsphere transcatheter arterial chemoembolization + bicarbonate; PD-1 = programmed cell death protein-1; PD-L1 = programmed cell death protein-1 ligand.